Geron Corporation

Results: 22



#Item
1Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

Add to Reading List

Source URL: www.geron.com

Language: English - Date: 2016-04-17 19:35:18
2BIO CEO & Investor Conference John Scarlett, M.D. President & CEO, Geron Corporation February 9, 2015

BIO CEO & Investor Conference John Scarlett, M.D. President & CEO, Geron Corporation February 9, 2015

Add to Reading List

Source URL: www.geron.com

Language: English - Date: 2015-02-09 14:00:19
    35. INTELLECTUAL PROPERTY OF HUMAN PLURIPOTENT STEM CELLS by Mark L. Rohrbaugh* his report will provide an update in the area of intellectual property issues related to human

    5. INTELLECTUAL PROPERTY OF HUMAN PLURIPOTENT STEM CELLS by Mark L. Rohrbaugh* his report will provide an update in the area of intellectual property issues related to human

    Add to Reading List

    Source URL: stemcells.nih.gov

    Language: English - Date: 2011-10-24 17:06:50
    44694 • The Journal of Neuroscience, May 11, 2005 • 25(19):4694 – 4705  Development/Plasticity/Repair Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore

    4694 • The Journal of Neuroscience, May 11, 2005 • 25(19):4694 – 4705 Development/Plasticity/Repair Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore

    Add to Reading List

    Source URL: www.jneurosci.org

    Language: English - Date: 2005-05-04 15:49:43
    5Day 2 of Bangalore India BIO dominated by sessions on Stem Cell Treatment, Bio Medical Innovation, Rare Disease & Orphan Drug and Vaccine Research India’s biggest event on biotechnology to cover the impact of biotechno

    Day 2 of Bangalore India BIO dominated by sessions on Stem Cell Treatment, Bio Medical Innovation, Rare Disease & Orphan Drug and Vaccine Research India’s biggest event on biotechnology to cover the impact of biotechno

    Add to Reading List

    Source URL: www.interlinks.in

    Language: English - Date: 2015-02-24 06:58:18
    6Nov to Dec[removed]A voice for equity, inclusiveness and empowerment ‘Disability will become diversity’

    Nov to Dec[removed]A voice for equity, inclusiveness and empowerment ‘Disability will become diversity’

    Add to Reading List

    Source URL: www.spinal.com.au

    Language: English - Date: 2010-12-16 20:28:44
    7Microsoft Word - FAQ Stem Cell ACA - Jan[removed]doc

    Microsoft Word - FAQ Stem Cell ACA - Jan[removed]doc

    Add to Reading List

    Source URL: www.biotimeinc.com

    Language: English - Date: 2013-01-07 12:59:35
    8ASH 2014 Analyst & Investor Event December 8, 2014 John A. Scarlett, M.D. President & CEO, Geron Corporation Steven Lane, M.D., Ph.D. Queensland Institute of Medical Research

    ASH 2014 Analyst & Investor Event December 8, 2014 John A. Scarlett, M.D. President & CEO, Geron Corporation Steven Lane, M.D., Ph.D. Queensland Institute of Medical Research

    Add to Reading List

    Source URL: www.geron.com

    Language: English - Date: 2014-12-08 20:41:08
    9Addendum to ATCC® MTA for TERT Products supplied to the NCI PBCF CONTRACT Noncommercial and Academic Organizations This Research Use License (the “Use License”) sets forth terms and conditions that are in addition t

    Addendum to ATCC® MTA for TERT Products supplied to the NCI PBCF CONTRACT Noncommercial and Academic Organizations This Research Use License (the “Use License”) sets forth terms and conditions that are in addition t

    Add to Reading List

    Source URL: pson.cancer.gov

    Language: English - Date: 2013-02-11 14:37:00
    10Addendum to ATCC® MTA for TERT Products supplied to the NCI PBCF CONTRACT Noncommercial and Academic Organizations This Research Use License (the “Use License”) sets forth terms and conditions that are in addition t

    Addendum to ATCC® MTA for TERT Products supplied to the NCI PBCF CONTRACT Noncommercial and Academic Organizations This Research Use License (the “Use License”) sets forth terms and conditions that are in addition t

    Add to Reading List

    Source URL: physics.cancer.gov

    Language: English - Date: 2013-02-11 14:37:00